Publicaciones (57) Publicaciones en las que ha participado algún/a investigador/a

2014

  1. "very early" intrahepatic cholangiocarcinoma in cirrhotic patients: Should liver transplantation be reconsidered in these patients?

    American Journal of Transplantation, Vol. 14, Núm. 3, pp. 660-667

  2. A GAPDH-mediated trans-nitrosylation pathway is required for feedback inhibition of bile salt synthesis in rat liver

    Gastroenterology, Vol. 147, Núm. 5, pp. 1084-1093

  3. A quick and efficient method to generate mammalian stable cell lines based on a novel inducible alphavirus DNA/RNA layered system

    Cellular and Molecular Life Sciences, Vol. 71, Núm. 23, pp. 4637-4651

  4. A role for cardiotrophin-1?

    Hypertension, Vol. 63, Núm. 3, pp. 468-474

  5. Adecuación de la tromboprofilaxis en pacientes que ingresan por patología médica desde los servicios de urgencias hospitalarios: Estudio PROTESU

    Emergencias, Vol. 26, Núm. 4, pp. 281-291

  6. Adenovirus expressing β2-microglobulin recovers HLA class i expression and antitumor immunity by increasing T-cell recognition

    Cancer Gene Therapy, Vol. 21, Núm. 8, pp. 317-332

  7. Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis

    HEPATIC ONCOLOGY, Vol. 1, Núm. 2, pp. 241-252

  8. Amphiregulin

    Seminars in Cell and Developmental Biology, Vol. 28, pp. 31-41

  9. Anion exchanger 2 is critical for CD8+ T cells to maintain pHi homeostasis and modulate immune responses

    European Journal of Immunology, Vol. 44, Núm. 5, pp. 1341-1351

  10. Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses

    Journal of Immunology, Vol. 193, Núm. 4, pp. 1787-1798

  11. Beneficio sobre la supervivencia con las técnicas intraarteriales en el carcinoma hepatocelular

    Gastroenterologia y Hepatologia, Vol. 37, Núm. S2, pp. 95-101

  12. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation

    Journal of Hepatology, Vol. 60, Núm. 5, pp. 1017-1025

  13. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection

    Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489

  14. Chemoembolization and radioembolization

    Best Practice and Research: Clinical Gastroenterology, Vol. 28, Núm. 5, pp. 909-919

  15. Circulating osteoprotegerin is increased in the metabolic syndrome and associates with subclinical atherosclerosis and coronary arterial calcification

    Clinical Biochemistry, Vol. 47, Núm. 18, pp. 272-278

  16. Clinical application of the COPD assessment test: Longitudinal data from the COPD history assessment in Spain (CHAIN) Cohort

    Chest, Vol. 146, Núm. 1, pp. 111-122

  17. Comparación de las sondas M y XL para estimar la rigidez hepática por medio de elastografía de transición

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 4, pp. 233-239

  18. Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: The VESSEL12 study

    Medical Image Analysis, Vol. 18, Núm. 7, pp. 1217-1232

  19. Conventional but not plasmacytoid dendritic cells foster the systemic virus-induced type I IFN response needed for efficient CD8 T cell priming

    Journal of Immunology, Vol. 193, Núm. 3, pp. 1151-1161

  20. Daptomycin in the treatment of prosthetic joint infection by Enterococcus faecalis: Safety and efficacy of high-dose and prolonged therapy

    International Journal of Infectious Diseases, Vol. 27, pp. 65-66